Daniel Arias
Stock Analyst at Stifel Nicolaus
(4.65)
# 863
Out of 5,076 analysts
523
Total ratings
52.4%
Success rate
12.2%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Reiterated: Buy | $220 → $260 | $230.50 | +12.80% | 28 | Oct 22, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $775 | $673.82 | +15.02% | 35 | Oct 22, 2026 | |
| ILMN Illumina | Reiterated: Buy | $225 | $269.42 | -16.49% | 50 | Sep 15, 2026 | |
| RGEN Repligen | Reiterated: Buy | n/a | $176.93 | - | 33 | Sep 15, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $180 | $173.07 | +4.00% | 28 | Aug 30, 2026 | |
| MXCT MaxCyte | Reiterated: Buy | $4 | $1.40 | +185.71% | 17 | Aug 13, 2026 | |
| MASS 908 Devices | Reiterated: Buy | $10 → $12 | $11.49 | +4.44% | 17 | Aug 12, 2026 | |
| ALMR Alamar Biosciences | Reiterated: Buy | $28 → $32 | $30.69 | +4.27% | 3 | Aug 11, 2026 | |
| MRVI Maravai LifeSciences Holdings | Reiterated: Buy | $6 → $8 | $7.32 | +9.29% | 25 | Aug 11, 2026 | |
| QGEN Qiagen | Reiterated: Hold | $40 | $50.39 | -20.62% | 21 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $71.55 | -30.12% | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.78 | +925.64% | 7 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $107.77 | +34.55% | 4 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $45 → $50 | $57.59 | -13.18% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $100 → $110 | $158.77 | -30.72% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $380 → $420 | $453.67 | -7.42% | 29 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 → $180 | $169.08 | +6.46% | 18 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,400 → $1,600 | $1,670.29 | -4.21% | 30 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $60 → $50 | $67.62 | -26.05% | 12 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $8 → $15 | $17.29 | -13.24% | 19 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $65 → $50 | $72.55 | -31.08% | 28 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.28 | +290.63% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $9.18 | n/a | 9 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.90 | n/a | 13 | Mar 1, 2024 |
Danaher
Oct 22, 2026
Reiterated: Buy
Price Target: $220 → $260
Current: $230.50
Upside: +12.80%
Thermo Fisher Scientific
Oct 22, 2026
Reiterated: Buy
Price Target: $775
Current: $673.82
Upside: +15.02%
Illumina
Sep 15, 2026
Reiterated: Buy
Price Target: $225
Current: $269.42
Upside: -16.49%
Repligen
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $176.93
Upside: -
Agilent Technologies
Aug 30, 2026
Reiterated: Buy
Price Target: $180
Current: $173.07
Upside: +4.00%
MaxCyte
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $1.40
Upside: +185.71%
908 Devices
Aug 12, 2026
Reiterated: Buy
Price Target: $10 → $12
Current: $11.49
Upside: +4.44%
Alamar Biosciences
Aug 11, 2026
Reiterated: Buy
Price Target: $28 → $32
Current: $30.69
Upside: +4.27%
Maravai LifeSciences Holdings
Aug 11, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $7.32
Upside: +9.29%
Qiagen
Aug 11, 2026
Reiterated: Hold
Price Target: $40
Current: $50.39
Upside: -20.62%
Aug 11, 2026
Reiterated: Buy
Price Target: $50
Current: $71.55
Upside: -30.12%
Aug 10, 2026
Reiterated: Buy
Price Target: $8
Current: $0.78
Upside: +925.64%
Aug 6, 2026
Reiterated: Buy
Price Target: $145
Current: $107.77
Upside: +34.55%
Aug 5, 2026
Reiterated: Hold
Price Target: $45 → $50
Current: $57.59
Upside: -13.18%
Aug 5, 2026
Rated: Hold
Price Target: $100 → $110
Current: $158.77
Upside: -30.72%
Aug 5, 2026
Rated: Hold
Price Target: $380 → $420
Current: $453.67
Upside: -7.42%
Aug 3, 2026
Reiterated: Buy
Price Target: $130 → $180
Current: $169.08
Upside: +6.46%
Aug 3, 2026
Reiterated: Buy
Price Target: $1,400 → $1,600
Current: $1,670.29
Upside: -4.21%
Aug 3, 2026
Reiterated: Hold
Price Target: $60 → $50
Current: $67.62
Upside: -26.05%
Jul 30, 2026
Rated: Hold
Price Target: $8 → $15
Current: $17.29
Upside: -13.24%
May 7, 2026
Reiterated: Hold
Price Target: $65 → $50
Current: $72.55
Upside: -31.08%
Nov 10, 2025
Reiterated: Buy
Price Target: $5
Current: $1.28
Upside: +290.63%
Jan 22, 2025
Rated: Hold
Price Target: n/a
Current: $9.18
Upside: n/a
Mar 1, 2024
Reiterated: Buy
Price Target: $5
Current: $3.90
Upside: n/a